This is the authors' abstract. We don't add key points for this paper.
1-Alkyl-2-(arylazo)imidazoles (p-R-C6H4-N=N-C3H2N2X, abbreviated as RaaiX, R = H(a), CH3(b), Cl(c); X = N(1)-CH3 (1), N(1)-CH2-C6H5 (2)) have been reacted with (NH4)2[OsCl6] and OsCl2(RaaiX)2 species isolated in two isomeric forms, blue-violet (3, 5) and red-violet (4, 6). IR spectra show two x (Os-Cl) modes and support a cis-OsCl2 configuration. X-ray diffraction methods were used to determine structures of blue-violet isomers. In terms of the three coordination pairs around Os(II), Cl, Cl, N, N (N(imidazole), N) and N', N' (N(azo), N') the blue-violet isomers have a cis-trans-cis (ctc) configuration. 1H NMR data for the red-violet complexes (isomers B) and results concerning analogous ruthenium(II) complexes indicate isomer B to have cis-cis-cis (ccc) configuration. Absorption spectra show an intense MLCT band at ca 580 nm along with two weak bands at 800 and 1000 nm. Cyclic voltammetry shows quasi-reversible Os(III)/Os(II) and Os(IV)/Os(III) couples at 0.4-0.6 V and 1.3-1.5 V versus SCE and ill-defined azo reductions. The X-Ray structures show unusually long N=N bond lengths, 1.31-1.32 Å, elongated by some 0.06 Å compared to the free ligand value. Os(II) prefers to bind N(azo) (Os-N(azo), 1.98 Å) rather than N(imidazole) (Os-N(imidazole), 2.03 Å). EHMO calculations of ctc-OsCl2 (MeaaiMe) and comparison with the ruthenium(II) complex account for the MLCT transitions in terms of a metal-dominated HOMO to a ligand-dominated LUMO shift.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Byabartta et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: